‌

US Patent 9447184 IL-1 binding proteins

Patent 9447184 was granted and assigned to AbbVie Inc. on September, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Chung-ming Hsieh0

Tariq Ghayur0

Chengbin Wu0

Dominic J. Ambrosi0

Date of Patent

September 20, 2016

Patent Application Number

14141317

Date Filed

December 26, 2013

Patent Citations Received

US Patent 11673946 Methods of treating a companion animal species comprising administering anti-IL31 antibodies

0

US Patent 11697683 Anti-IL31 antibodies for veterinary use

0

US Patent 11999783 Method of treating autoimmune disease with antibodies against IL-33

0

US Patent 11679101 Anhydrous compositions of mTOR inhibitors and methods of use

0

Patent Primary Examiner

Patent abstract

Proteins that bind IL-1α and IL-1β are described along with their use in compositions and methods for treating, preventing, and diagnosing IL-1-related disorders and for detecting IL-1α and IL-1β in cells, tissues, samples, and compositions.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9447184 IL-1 binding proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.